AstraZeneca Total Assets vs Capital Surpluse Analysis
AZN Stock | USD 76.35 0.55 0.73% |
AstraZeneca PLC financial indicator trend analysis is way more than just evaluating AstraZeneca PLC ADR prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AstraZeneca PLC ADR is a good investment. Please check the relationship between AstraZeneca PLC Total Assets and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Total Assets vs Capital Surpluse
Total Assets vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AstraZeneca PLC ADR Total Assets account and Capital Surpluse. At this time, the significance of the direction appears to have strong relationship.
The correlation between AstraZeneca PLC's Total Assets and Capital Surpluse is 0.63. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of AstraZeneca PLC ADR, assuming nothing else is changed. The correlation between historical values of AstraZeneca PLC's Total Assets and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of AstraZeneca PLC ADR are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Assets i.e., AstraZeneca PLC's Total Assets and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.63 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of AstraZeneca PLC assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AstraZeneca PLC ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Capital Surpluse
Most indicators from AstraZeneca PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AstraZeneca PLC ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. At this time, AstraZeneca PLC's Tax Provision is very stable compared to the past year. As of the 4th of May 2024, Enterprise Value is likely to grow to about 220.4 B, while Selling General Administrative is likely to drop about 11.8 B.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.3B | 1.3B | 1.6B | 1.7B | Depreciation And Amortization | 6.5B | 5.6B | 4.9B | 5.2B |
AstraZeneca PLC fundamental ratios Correlations
Click cells to compare fundamentals
AstraZeneca PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AstraZeneca PLC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 61.4B | 66.7B | 105.4B | 96.5B | 101.1B | 106.2B | |
Short Long Term Debt Total | 18.2B | 20.4B | 30.8B | 29.2B | 28.6B | 30.1B | |
Other Current Liab | 2.1B | 508M | 748M | 1.5B | 21.7B | 22.8B | |
Total Current Liabilities | 18.1B | 20.3B | 22.6B | 26.3B | 30.5B | 32.1B | |
Total Stockholder Equity | 13.1B | 15.6B | 39.3B | 37.0B | 39.1B | 41.1B | |
Property Plant And Equipment Net | 8.3B | 8.9B | 10.2B | 9.4B | 10.5B | 6.8B | |
Net Debt | 12.9B | 12.5B | 24.5B | 23.1B | 22.8B | 23.9B | |
Retained Earnings | 2.8B | 5.3B | 1.7B | (574M) | 1.5B | 1.4B | |
Accounts Payable | 14.0B | 15.8B | 18.9B | 19.0B | 3.3B | 3.1B | |
Cash | 5.4B | 7.8B | 6.3B | 6.2B | 5.8B | 4.7B | |
Non Current Assets Total | 45.8B | 47.2B | 79.1B | 73.9B | 76.1B | 79.9B | |
Non Currrent Assets Other | 1.5B | 1.7B | 1.1B | 1.1B | 1.1B | 1.4B | |
Cash And Short Term Investments | 6.2B | 8.0B | 6.4B | 6.4B | 5.9B | 5.8B | |
Common Stock Shares Outstanding | 2.6B | 2.6B | 2.9B | 3.1B | 3.1B | 2.9B | |
Liabilities And Stockholders Equity | 61.4B | 66.7B | 105.4B | 96.5B | 101.1B | 106.2B | |
Non Current Liabilities Total | 28.7B | 30.8B | 43.5B | 33.1B | 31.4B | 33.0B | |
Inventory | 3.2B | 4.0B | 9.0B | 4.7B | 5.4B | 5.7B | |
Total Liab | 46.8B | 51.1B | 66.1B | 59.4B | 62.0B | 65.1B | |
Total Current Assets | 15.6B | 19.5B | 26.2B | 22.6B | 25.1B | 15.3B | |
Short Term Debt | 2.0B | 2.4B | 1.9B | 5.5B | 5.4B | 5.7B | |
Other Stockholder Equity | 8.4B | 8.4B | 35.6B | 35.6B | 35.6B | 37.4B | |
Other Assets | 3.5B | 4.3B | 5.3B | 4.2B | 4.8B | 5.0B | |
Intangible Assets | 20.8B | 20.9B | 42.4B | 39.3B | 38.1B | 40.0B | |
Other Liab | 10.3B | 10.5B | 13.0B | 8.5B | 9.8B | 6.7B | |
Long Term Debt | 15.7B | 17.5B | 28.1B | 23.0B | 22.4B | 11.3B | |
Good Will | 11.7B | 11.8B | 20.0B | 19.8B | 20.0B | 21.1B | |
Other Current Assets | 971M | 1.9B | 105M | 11.5B | 116M | 110.2M | |
Property Plant Equipment | 8.3B | 8.9B | 10.2B | 9.4B | 10.9B | 7.9B | |
Current Deferred Revenue | 28M | 1.6B | 1.0B | 181M | 149M | 156.5M | |
Net Receivables | 5.2B | 5.7B | 10.8B | 9.9B | 13.6B | 14.2B | |
Property Plant And Equipment Gross | 8.3B | 8.9B | 10.2B | 9.4B | 19.1B | 20.1B | |
Accumulated Other Comprehensive Income | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.7B | |
Noncontrolling Interest In Consolidated Entity | 1.6B | 1.5B | 16M | 21M | 23M | 21.9M | |
Additional Paid In Capital | 8.1B | 8.1B | 35.3B | 35.3B | 35.3B | 37.1B | |
Net Tangible Assets | (19.4B) | (17.2B) | (23.1B) | (22.1B) | (19.9B) | (20.9B) |
AstraZeneca PLC Investors Sentiment
The influence of AstraZeneca PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AstraZeneca. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AstraZeneca PLC's public news can be used to forecast risks associated with an investment in AstraZeneca. The trend in average sentiment can be used to explain how an investor holding AstraZeneca can time the market purely based on public headlines and social activities around AstraZeneca PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AstraZeneca PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AstraZeneca PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AstraZeneca PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AstraZeneca PLC.
AstraZeneca PLC Implied Volatility | 22.07 |
AstraZeneca PLC's implied volatility exposes the market's sentiment of AstraZeneca PLC ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AstraZeneca PLC's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AstraZeneca PLC stock will not fluctuate a lot when AstraZeneca PLC's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AstraZeneca PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AstraZeneca PLC's short interest history, or implied volatility extrapolated from AstraZeneca PLC options trading.
Pair Trading with AstraZeneca PLC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.Moving against AstraZeneca Stock
0.83 | INTC | Intel Financial Report 25th of July 2024 | PairCorr |
0.63 | SRBBF | VPN Technologies | PairCorr |
0.61 | IBM | International Business Financial Report 17th of July 2024 | PairCorr |
0.61 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
0.57 | IRNRF | Iron Road Limited | PairCorr |
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.207 | Dividend Share 2.9 | Earnings Share 2.02 | Revenue Per Share 2.5512 | Quarterly Revenue Growth 0.165 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.